
Ironwood Pharma (IRWD) Stock Forecast & Price Target
Ironwood Pharma (IRWD) Analyst Ratings
Based on 26 analyst ratings
Hold
Strong Buy 27%
Buy 8%
Hold 62%
Sell 0%
Strong Sell 4%
Ironwood Pharma (IRWD) has been analyzed by 26 analysts, with a consensus rating of Hold. 27% of analysts recommend a Strong Buy, 8% recommend Buy, 62% suggest Holding, 0% advise Selling, and 4% predict a Strong Sell.
This aggregate rating is based on analysts' research of Ironwood Pharma and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Ironwood Pharma and is not a guaranteed prediction by Public.com or investment advice.
Ironwood Pharma (IRWD) Analyst Forecast & Price Prediction
Get the latest Ironwood Pharma (IRWD) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in Ironwood Pharma (IRWD)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Ironwood Pharma (IRWD) Forecast
Analysts have given Ironwood Pharma (IRWD) a Hold based on their latest research and market trends.
According to 26 analysts, Ironwood Pharma (IRWD) has a Hold consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $13.05, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $13.05, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.